ArticleClinical and translational science2022

Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel.

Uta Schilling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.